| Name | Title | Contact Details |
|---|
Lovelace Respiratory Research Institute is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Lovelace Respiratory Research Institute is based in Albuquerque, NM. You can find more information on Lovelace Respiratory Research Institute at www.lrri.org
Eastern Healthcare Group is a healthcare company that operates specialized nursing facilities across the state of Virginia. They focus on providing holistic care to their patients, with a commitment to creating a nurturing, family-like atmosphere.
XIFIN, Inc. is an innovative software and services company dedicated to optimizing the economics of healthcare. The company`s cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making.
KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.
PreMark Health ScienceNutraceutical and cosmeceutical products and packaging. PreMark provides end-to-end product solutions for nutrition and personal care products, from product development and formulation, to blending, manufacturing and packaging. Co...